STUDIES TO SLOW OR STOP PARKINSON S DISEASE. MJFF Third Thursdays Webinar October 15, 2015
|
|
- Theodore Rogers
- 6 years ago
- Views:
Transcription
1 STUDIES TO SLOW OR STOP PARKINSON S DISEASE MJFF Third Thursdays Webinar October 15, 2015
2 WHAT WE LL COVER TODAY What are the varied approaches to stop Parkinson s? How can our immune system help fight Parkinson s disease? What have we learned from observing people with PD? What happened to neurotrophic factors? Why is it so difficult to test a therapy that modifies the disease process? 2
3 OUR PANELISTS Moderator: Dave Iverson Founding Member, MJFF Patient Council Panelists: Bill Shepherd Chief Financial Officer, Global Wealth and Investment Management, Bank of America MJFF Leadership Council Member Lorraine V. Kalia, MD, PhD, FRCPC Neurologist, Toronto Western Hospital Assistant Professor, University of Toronto Todd Sherer, PhD CEO, The Michael J. Fox Foundation 3
4 HOW ARE WE TRYING TO STOP PARKINSON S? oprevent, break up or clear out toxic clumps of the protein alpha-synuclein olearn from other studies what compounds are associated with lower risk of PD and/or slower progression ointroduce therapies that protect brain cells There are many therapies with the potential to slow or stop PD already in human testing. 4
5 HOW CAN OUR IMMUNE SYSTEM HELP FIGHT PARKINSON S? Antibodies are Y-shaped proteins that identify and neutralize harmful viruses and bacteria. Parkinson s researchers are using antibodies to neutralize clumps of the protein alpha-synuclein, which clog up cells and lead to cell death. Two companies are injecting alpha-synuclein antibodies. One company is injecting fake alpha-synuclein to make the body produce natural antibodies (how the flu vaccine works). 5
6 COULD WE PREVENT THE TOXIC CLUMPS? Another company is testing a drug that stabilizes alpha-synuclein before it can form toxic clumps (called Lewy bodies). This trial is testing in people without Parkinson s, the first step to evaluate safety. If the drug is safe, they ll move to testing in people with PD. 6
7 WHAT DO WE SEE THAT MAY HELP SLOW PARKINSON S? Observations from other studies give us ideas for new therapies. Hypertension Drug (Isradipine): People taking this calcium channel blocker were at lower risk of Parkinson s. Lab tests show isradipine could be neuroprotective. Phase III trial (STEADY-PD) testing same drug for slowing PD Antioxidant Urate Precursor (Inosine): High levels of urate were associated with lower risk of PD or slower progression. Lab tests show inosine could be neuroprotective. Phase III trial (SURE-PD) testing compound the body turns into urate Phase III is the last step before applying for FDA approval. 7
8 WHAT DO WE SEE THAT MAY HELP SLOW PARKINSON S? Observations from other studies give us ideas for new therapies. Nicotine: PD is less prevalent among smokers compared to non-smokers. NIC-PD is testing the impact of nicotine patches on progression. We don t recommend taking up smoking to treat Parkinson s disease. 8
9 WHAT HAPPENED TO NEUROTROPHIC FACTORS? Neurotrophic factors are a family of proteins responsible for the growth of developing neurons and the maintenance of mature neurons. 9
10 WHAT HAPPENED TO NEUROTROPHIC FACTORS? Neurotrophic factors can t be given in a pill, requires brain surgery Only want to grow the neurons killed by disease Scientists are improving delivery methods to: Use enough of the therapy In the right place in the brain For the right amount of time Two studies are ongoing to test these improved methods Also, exercise can help boost neurotrophic factors 10
11 WHY IS IT SO DIFFICULT TO TEST DISEASE-MODIFYING THERAPIES? 1. Clinical trials need hundreds of volunteers. 2. We need a definitive way to choose the right people for studies and to measure the impact of new therapies on disease. Biomarkers: biological characteristics that alert us to risk, onset or progression of disease Scientists are working toward imaging Parkinson s in the brain, measuring proteins in fluid and tissue, and improving clinical measures. 11
12 QUESTIONS & ANSWERS Type your questions in the Q&A box in the middle of your screen. We ll get to as many as we can in this hour.
13 PARTICIPATE IN CLINICAL RESEARCH: foxtrialfinder.org WATCH PREVIOUS WEBINARS: michaeljfox.org/webinars This activity is supported by educational grants from Acadia, Teva and Medtronic. While our generous sponsors make Third Thursdays webinars possible, their support does not influence MJFF s content, perspective or panelist selection.
WHO, WHAT, WHEN AND WHERE OF PARKINSON S DIAGNOSIS. MJFF Third Thursdays Webinar March 17, 2016
WHO, WHAT, WHEN AND WHERE OF PARKINSON S DIAGNOSIS MJFF Third Thursdays Webinar March 17, 2016 WHAT WE LL COVER TODAY How is Parkinson s misdiagnosed? How is Parkinson s diagnosed today? Can we use DaTscan
More informationREPURPOSED THERAPIES IN PARKINSON S DISEASE
REPURPOSED THERAPIES IN PARKINSON S DISEASE What Patients and Families Need to Know Rachel Dolhun, MD Vice President, Medical Communications The Michael J. Fox Foundation Repurposing testing drugs often
More informationTreatment of Parkinson s Disease: Present and Future
Treatment of Parkinson s Disease: Present and Future Karen Blindauer, MD Professor of Neurology Director of Movement Disorders Program Medical College of Wisconsin Neuropathology: Loss of Dopamine- Producing
More informationINTRODUCTION TO FOX TRIAL FINDER. Accelerating Clinical Trial Recruitment Online
INTRODUCTION TO FOX TRIAL FINDER Accelerating Clinical Trial Recruitment Online MJFF WAS FOUNDED WITH CLEAR OBJECTIVES Drive the best Parkinson s disease research Deliver improved therapies and a cure
More informationKelly Mills, MD, MHS Johns Hopkins Parkinson s Disease and Movement Disorders Center
Kelly Mills, MD, MHS Johns Hopkins Parkinson s Disease and Movement Disorders Center Disclosures Research support from St. Jude / Abbott Funding National Institutes of Health / NINDS Parkinson Foundation
More informationWhat are the Latest Treatment Advances in Parkinson disease
What are the Latest Treatment Advances in Parkinson disease Fatta B. Nahab, M.D. Associate Professor of Neurosciences Director, Functional Imaging of Neurodegenerative Disorders Lab Overview Recently approved
More information2017 Research Year in Review
2017 Research Year in Review Extraordinary trends have been evident in Parkinson s disease (PD) research for the past several years, and 2017 was no exception. The PD drug development pipeline, once stalled
More informationDave Iverson: [00:00:30]
Michael J Fox: [00:00:30] [00:01:00] [00:01:30] [00:02:00] [00:02:30] [00:03:00] [00:03:30] This is Michael J. Fox. Thanks for listening to this podcast. Learn more about the Michael J. Fox Foundation's
More informationTHIS IS NOT YOUR GRANDMOTHER S DISEASE: WHAT DOES BEING DIAGNOSED WITH PARKINSON S DISEASE MEAN TODAY?
THIS IS NOT YOUR GRANDMOTHER S DISEASE: WHAT DOES BEING DIAGNOSED WITH PARKINSON S DISEASE MEAN TODAY? THURSDAY MARCH 14, 2019 REBECCA GILBERT, MD, PHD VICE PRESIDENT, CHIEF SCIENTIFIC OFFICER, APDA AMERICAN
More informationDesigning patient-centered clinical trials: Results of the MDIC project to use patient preference information to design clinical trials
1 Informative series of workshops featuring emerging trends in medical technology regulatory science, MDIC projects and subject matter experts sharing perspectives, progress and opportunities. Designing
More informationTHE MICHAEL J. FOX FOUNDATION FOR PARKINSON S RESEARCH. Funding Opportunities
THE MICHAEL J. FOX FOUNDATION FOR PARKINSON S RESEARCH Funding Opportunities AGENDA 1. Brief Overview of MJFF Philosophy 2. MJFF Funding Programs 3. How to apply 4. What happens next? 5. Q&A Please feel
More informationMAT Mathematics in Today's World
MAT 1000 Mathematics in Today's World Last Time 1. What does a sample tell us about the population? 2. Practical problems in sample surveys. Last Time Parameter: Number that describes a population Statistic:
More informationWelcome and Introductions
Parkinson s Disease Spotlight on Treatment Advances Tuesday, January 26, 2016 Welcome and Introductions Stephanie Paul Vice President Development and Marketing American Parkinson Disease Association 1
More informationSteps Against Recurrent Stroke (STARS)
Steps Against Recurrent Stroke (STARS) Take steps against recurrent stroke by making the necessary changes in your life. Your Guide to Ischemic Stroke What happened to me? You had a stroke. The stroke
More informationimmunotherapy a guide for the patient
immunotherapy FOR LUNG CANCER a guide for the patient TABLE OF CONTENTS lung cancer basics... 2 immunotherapy... 5 Checkpoint Inhibitors... 6-9 Monoclonal Antibodies... 9 Vaccines... 10 Adoptive T-Cell
More informationClinical Trial Glossary
Clinical Trial Glossary Adverse event An unfavorable change in health that can occur during a clinical trial or study or within a certain time period after. These can range from mild (e.g., nausea) to
More informationEngaging with FDA: A Guide for Foundation Funders of Research. FasterCures Webinar Series presents. April 18, 2012
FasterCures Webinar Series presents Engaging with FDA: A Guide for Foundation Funders of Research April 18, 2012 Moderated by Margaret Anderson Executive Director, FasterCures Engaging with FDA: A Guide
More informationWhat You Need to Know About Lung Cancer Immunotherapy
What You Need to Know About Lung Cancer Immunotherapy Lung.org/immunotherapy What is immunotherapy? Immunotherapy for cancer, sometimes called immune-oncology, is a type of medicine that treats cancer
More informationWhat s the Latest in Prostate Cancer Immunotherapy Options?
What s the Latest in Prostate Cancer Immunotherapy Options? Jeri Kim, MD Associate Professor, Department of Geritourinary Medical Oncology The University of Texas MD Anderson Cancer Center Sumit K. Subudhi,
More informationIMMUNOTHERAPY FOR LUNG CANCER
IMMUNOTHERAPY FOR LUNG CANCER Patient and Caregiver Guide IMMUNOTHERAPY FOR LUNG CANCER Patient and Caregiver Guide TABLE OF CONTENTS Lung Cancer Basics... 2 Immunotherapy... 3 FDA Approved Immunotherapies...
More informationSteps Against Recurrent Stroke (STARS)
Steps Against Recurrent Stroke (STARS) Take steps against recurrent stroke by making the necessary changes in your life Your Guide to Ischemic What Happened to Me? You had a stroke. The stroke you had
More informationEXPLORING OPPORTUNITIES TO PARTNER TOWARD CURES FOR PD. Chicago Clinical Research Fair June 11, 2016
EXPLORING OPPORTUNITIES TO PARTNER TOWARD CURES FOR PD Chicago Clinical Research Fair June 11, 2016 HOW DO WE LEARN MORE ABOUT PARKINSON S DISEASE? Patient-reported data Diagnosis and clinical symptoms
More informationUSING PRECISION MEDICINE TO HELP PATIENTS WITH PARKINSON S DISEASE. The Michael J. Fox Foundation for Parkinson s Research
USING PRECISION MEDICINE TO HELP PATIENTS WITH PARKINSON S DISEASE The Michael J. Fox Foundation for Parkinson s Research MJFF IS THE WORLD S LARGEST NONPROFIT FUNDER OF PD RESEARCH Our Mission We are
More informationWhat You Need to Know About Clinical Trials A Guide for People With Cancer
Developed by Pfizer in partnership with the Colon Cancer Alliance. What You Need to Know About Clinical Trials A Guide for People With Cancer THE VOICE OF SURVIVORS Why You Need to Know About Clinical
More informationCommunicating the Risk of Nicotine Delivery Products
Communicating the Risk of Nicotine Delivery Products August 10, 2014 ACS National Meeting Jim Solyst June 24, 2014 1 Nicotine Background Key Points The popularity of e-cigarettes has increased the need
More informationImproving diagnosis of Alzheimer s disease and lewy body dementia. Brain TLC October 2018
Improving diagnosis of Alzheimer s disease and lewy body dementia Brain TLC October 2018 Plan for this discussion: Introduction to AD and LBD Why do we need to improve diagnosis? What progress has been
More informationSUPPORT FEDERAL FUNDING FOR PARKINSON S DISEASE RESEARCH AND DRUG DEVELOPMENT
SUPPORT FEDERAL FUNDING FOR PARKINSON S DISEASE RESEARCH AND DRUG DEVELOPMENT Parkinson s disease (PD) affects an estimated 750,000 to 1 million Americans. Currently, there is no treatment to slow, stop
More informationPathogens and disease
Pathogens and disease Task 1: Have a go at completing the exam questions for 35 minutes. Task 2: Review the mark scheme and touch up on the areas we need to work on. Pathogens and disease Pathogens: Microorganisms
More informationDisclaimer. Dialogue with a Patient 3/18/2016
Medical Affairs and Scientific Communications 2016 Annual Forum Dialogue with a Patient Bill Wilkins, Co-Founder, Executive Director, Wilkins Parkinsons Foundation March 21-23 Kissimmee, FL Disclaimer
More informationTaking Part in Cancer Treatment Research Studies
Taking Part in Cancer Treatment Research Studies U.S. Department of Health & Human Services National Institutes of Health Taking Part in Cancer Treatment Research Studies If you have cancer, you may want
More informationCarla Knapp, National Director Native Services
Carla Knapp, National Director Native Services Today s Objectives Understand the 2025 Strategic Direction Identify alignment with your organization s plans Learn how Native Services can help in partnership
More informationNavigating Clinical Trials. A Guide for Parkinson s Patients and Families
Navigating Clinical Trials A Guide for Parkinson s Patients and Families Cures aren t going to fall from the sky. We have to climb up and get them. Michael J. Fox Table of Contents 02 A Letter from The
More informationParkinson s Disease Webcast January 31, 2008 Jill Ostrem, M.D. What is Parkinson s Disease?
Parkinson s Disease Webcast January 31, 2008 Jill Ostrem, M.D. Please remember the opinions expressed on Patient Power are not necessarily the views of UCSF Medical Center, its medical staff or Patient
More informationName Date Germs Make Me Sick! by Melvin Berger Vocabulary Word Unscramble Unscramble the words. Use the words in the text box for help.
Vocabulary Word Unscramble Unscramble the words. Use the words in the text box for help. germs ache bacteria viruses shapes microscope breathe harmful cells proteins antibodies multiply waste poisons damaged
More informationWhat are the different sense organs, and what do they sense? What are the 5 senses? What is the job of the nervous system?
What are the 5 senses? What are the different sense organs, and what do they sense? What is the job of the nervous system? What is the nervous system made up of? What is a receptor? Give some examples
More informationEMERGING TREATMENTS FOR PARKINSON S DISEASE
EMERGING TREATMENTS FOR PARKINSON S DISEASE Katerina Markopoulou, MD, PhD Director Neurodegenerative Diseases Program Department of Neurology NorthShore University HealthSystem Clinical Assistant Professor
More informationEvery day matters. To help you stay out of the hospital, you can: Live healthy with sickle cell disease
Living with sickle cell disease (SCD) can be difficult. There can be severe pain and discomfort. AmeriHealth Caritas Louisiana wants to help you manage this life-threatening disease. To help you stay out
More informationProtecting Brain Health: Chronic Dz Prevention, Risk Management in Alzheimer s Disease
Protecting Brain Health: Chronic Dz Prevention, Risk Management in Alzheimer s Disease Victor A. Hirth, MD, MHA, FACP, AGSF Professor & Chief Division of Geriatrics USC, School of Medicine Medical Director
More informationEngaging with FDA for Better Lung Cancer Treatments. August 6, 2013 American Lung Association
Engaging with FDA for Better Lung Cancer Treatments August 6, 2013 American Lung Association Agenda Background on FDA s initiative Patient & survivor views How can you share your thoughts? Other opportunities
More informationDr. Michael Lobatz Dr. Michael Jackson Dr. James Brewer Dr. Paul Aisen. Dr. Michael Plopper. Dr. Guerry Peavy
1 Anne State 2 3 Dr. Michael Lobatz Dr. Michael Jackson Dr. James Brewer Dr. Paul Aisen Dr. Michael Plopper Dr. Guerry Peavy 4 Michael Lobatz, MD Medical Director, Neurosciences Medical Director, Rehabilitation
More information2017 Phoenix Clinical Research Fair Program of Events
2017 Phoenix Clinical Research Fair Program of Events From 8:45 a.m. Check-in Second Floor of the Conference Center 8:45 a.m. 1:00 p.m. Trial Exhibition Second Floor of the Conference Center 9:30 a.m.
More informationSteps Against Recurrent Stroke (STARS)
Steps Against Recurrent Stroke (STARS) Take steps against recurrent stroke by making the necessary changes in your life. Your Guide to Ischemic What happened to me? You had a stroke. The stroke you had
More informationInvestigating Plinabulin for Prevention of Chemotherapy-Induced Neutropenia
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/project-oncology/origins-and-impacts-severe-neutropenia-newpharmacotherapy/9650/
More informationVery Short Notes. Short Notes. 1 placebo definition 2 placebo effect definition
Chapter 5 The Placebo Effect Notes and Transcript When you make a speech or presentation, you want to know the material very well, even if you have notes and a transcript to look at. You can learn the
More informationWG Fresh Start manual. A guide to getting you on the road to a fresh start. P15630 Quit Manual.indd 1 03/08/ :48
WG14403 Fresh Start manual A guide to getting you on the road to a fresh start P15630 Quit Manual.indd 1 03/08/2012 09:48 Fresh Start Wales can help you become smoke free for good and reading this pack
More informationDamage to the myelin sheaths of neurones can lead to problems controlling the contraction of muscles
Q1.Multiple sclerosis (MS) is a disease that involves damage to the myelin sheaths of neurones. Movement in MS sufferers may be jerky or slow. (a) Damage to the myelin sheaths of neurones can lead to problems
More informationPreventing Communicable Diseases
Preventing Communicable Diseases Notes: Welcome to the Health 9 Lesson: Preventing Communicable Diseases. Please click the next button to continue. Notes: There are many ways to prevent communicable diseases.
More informationOrigins. Update on Parkinson s Disease
Update on Parkinson s Disease Melinda Burnett, MD Origins First described in 1817 by James Parkinson: Involuntary tremulous motion, with lessened muscular power, in parts not in action and even when supported;
More informationSoutheastern Montana Tobacco Use Prevention Program
Southeastern Montana Tobacco Use Prevention Program Tobacco Free Parks On the 23 of May, 2 Forsyth youth attended the city council meeting to explain to council members the importance of having tobacco
More informationThe Benefits of Cardio Flow
The Benefits of Cardio Flow Cardiovascular disease the number one killer Today, one in four people will suffer from heart disease. Over half of the heart attacks that occur this year will result in sudden
More informationTranscript of Cerebrum Podcast Fire in the Smoke: Battling Brain Tumors
Transcript of Cerebrum Podcast Fire in the Smoke: Battling Brain Tumors Guest: Michael Lim, M.D., is director of the Brain Tumor Immunotherapy Program and a professor of neurosurgery, oncology, otolaryngology,
More informationDay 3: Day 1: Day 2: You are infected. Visit the medical team. Will you live or die?
is coming! Day 1: starts in one place in the school. Each sufferer can infect up to 4 others. F Day 2: passes from class to class. Your health is in danger. Day 3: You are infected. Visit the medical team.
More informationHealth HAPPEN. Make. Starting January 1, 2019, we're adding new Healthy Rewards!
Make Health HAPPEN Vol. 4, 2018 www.myamerigroup.com/ia Starting January 1, 2019, we're adding new Healthy Rewards! Your health is our priority! And our Healthy Rewards program is here to help you stay
More informationWelcome to today s webinar
Welcome to today s webinar We will begin the webinar at 2:00 p.m. Eastern All attendee lines are automatically muted. This webinar is being recorded and will be posted on LBDA s Youtube page. Throughout
More informationWorking Together To Outrun Cancer
Lesson: Talking to Students About Cancer Curriculum Connection: Language Arts / Health Education Grade Level: Primary Time: Approximately 40-60 minutes Lesson Snapshot Sometimes teachers wonder how they
More informationIRB Approval From: 3/8/2010 To: 10/28/2010
UNIVERSITY OF PENNSYLVANIA HEALTH SYSTEM Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Swine-Origin H1N1 Influenza Vaccine in HIV-1 (Version 3.0, 16 FEB 2010) IRB Approval From:
More informationUPDATE ON RESEARCH IN PARKINSON S DISEASE
UPDATE ON RESEARCH IN PARKINSON S DISEASE Charles H. Adler, M.D., Ph.D. Professor of Neurology Mayo Clinic College of Medicine Co-Principal Investigator Arizona Parkinson s Disease Consortium Arizona Study
More informationMJFF S VISION FOR PARTNERING WITH PATIENTS. Sohini Chowdhury The Michael J. Fox Foundation
MJFF S VISION FOR PARTNERING WITH PATIENTS Sohini Chowdhury The Michael J. Fox Foundation OUR SINGLE, URGENT GOAL: CURE PARKINSON S DISEASE MJFF s Mission The Michael J. Fox Foundation is dedicated to
More informationLET S TALK about Sticking with your treatment plan
LET S TALK about Sticking with your treatment plan HOW ONGOING HIV CARE HELPS YOU LIVE A LONGER AND HEALTHIER LIFE Your treatment plan is vital to your overall health (and to reducing HIV transmission)
More informationCDNF: Finnish academia-industry collaboration for unique clinical study in Parkinson s disease
CDNF: Finnish academia-industry collaboration for unique clinical study in Parkinson s disease Brain Diseases Symposium, Helsinki 14 Oct 2016 Pekka Simula, CEO, Herantis Pharma Plc 1 Disclaimer This presentation
More informationWelcome Pioneers for Smoking Cessation
Welcome Pioneers for Smoking Cessation To Smoke or Not to Smoke: That is the Adolescent Question Tuesday, November 1, 2011-1:00 pm ET During the Webinar Tip: If you do not see the Join Teleconference popup
More informationBiology Unit Biology B1a (Human Biology)
Centre Number Candidate Number Surname Other Names Candidate Signature General Certificate of Secondary Education Foundation Tier and Higher Tier November 2010 Science A Unit Biology B1a (Human Biology)
More informationWeighty Matters. Health & Medicine
Health & Medicine Weighty Matters Michael Rosenbaum, a professor of pediatrics and medicine at Columbia University Medical Center, is one of the world s leading experts in obesity. He also directs the
More informationTRACKING PARKINSON S DISEASE. Wearable devices and big data analytics amplify the patient voice in Parkinson s drug development.
MARK SELIGER THE FOX FOCUS ON PARKINSON S FALL 2014 NEWSLETTER TRACKING PARKINSON S DISEASE Wearable devices and big data analytics amplify the patient voice in Parkinson s drug development. by maggie
More informationSNC2D BIOLOGY 3/24/2013. TISSUES, ORGANS & SYSTEMS OF L Cancer Cell Division Gone Wrong (P.32-34) Cancer Cell Division Gone Wrong
SNC2D BIOLOGY TISSUES, ORGANS & SYSTEMS OF L Cancer Cell Division Gone Wrong (P.32-34) Cancer Cell Division Gone Wrong A cell s DNA controls everything that happens in that cell, including cell division.
More informationYour legacy. An end to lung disease. How a gift in your will could help stop future generations suffering.
Your legacy An end to lung disease How a gift in your will could help stop future generations suffering. By remembering the British Lung Foundation in your will, you can help us lead the fight against
More informationPD ExpertBriefing: What s in the Parkinson s Pipeline
PD ExpertBriefing: What s in the Parkinson s Pipeline Presented by: David G. Standaert, M.D., Ph.D. Professor of Neurology Director, Center for Neurodegeneration and Experimental Therapeutics University
More informationPersonalized Therapies for Lung Cancer. Questions & Answers
Personalized Therapies for Lung Cancer Questions & Answers What are Personalized Therapies for lung cancer? Like people, no two lung cancer tumors are the same. Personalized medicine (also known as precision
More informationX-Plain Hepatitis B Reference Summary
X-Plain Hepatitis B Reference Summary Introduction Hepatitis B is the most common serious liver infection. It is caused by the hepatitis B virus that attacks the liver. The virus is transmitted through
More informationScott J Sherman MD, PhD The University of Arizona PARKINSON DISEASE
Scott J Sherman MD, PhD The University of Arizona PARKINSON DISEASE LEARNING OBJECTIVES The Course Participant will: 1. Be familiar with the pathogenesis of Parkinson s Disease (PD) 2. Understand clinical
More informationSHOULD THE US DEVELOP AND STOCKPILE VACCINES AGAINST A(H5N1) When first reading this question, one s instinct is of course to say yes!
Kathleen Tait Biology 501 July 7, 2006 SHOULD THE US DEVELOP AND STOCKPILE VACCINES AGAINST A(H5N1) AVIAN FLU? When first reading this question, one s instinct is of course to say yes! This would be a
More information2/20/2019. The need for adult vaccinations. Update on Adult Immunizations. The Need for Adult Vaccinations. Objectives:
The need for adult vaccinations Update on Adult Immunizations Objectives: Recall the latest recommendations on adult vaccinations Detail the importance of adult vaccinations I m not a kid.. Why are you
More informationImmune System AP SBI4UP
Immune System AP SBI4UP TYPES OF IMMUNITY INNATE IMMUNITY ACQUIRED IMMUNITY EXTERNAL DEFENCES INTERNAL DEFENCES HUMORAL RESPONSE Skin Phagocytic Cells CELL- MEDIATED RESPONSE Mucus layer Antimicrobial
More informationQuestion What is the function of the immune system? Answer:
Q1 How quickly do bacteria reproduce in ideal conditions? Every 20 minutes. Q2 If you start with 1 bacterium that reproduces every 20 minutes, how many bacteria will you have after 5 hours? 32768 Q3 Give
More informationSmoking Cessation: A readily modifiable risk factor
Robert L. Keith MD FCCP Associate Professor of Medicine Medical Director of Respiratory Therapy Eastern Colorado Health Care System University of Colorado Denver Smoking Cessation: A readily modifiable
More informationABOUT TYPE 2 DIABETES
ABOUT TYPE 2 DIABETES Because the more you know, the better you ll feel. What You ll Find Attitudes and Beliefs Type 2 Diabetes What Is It? Where You ll Find It Page 4-5 This booklet is designed to help
More informationPNEUMONIA. Your Treatment and Recovery
PNEUMONIA Your Treatment and Recovery Understanding Pneumonia Symptoms of Pneumonia Do you feel feverish and tired, with a cough that won t go away? If so, you may have pneumonia. This is a lung infection
More informationPoll Question.
Poll Question > Why did you decide to join today s webinar? My agency has successfully implemented CD and I m curious how it is working at another agency My agency has implemented CD but faces continued
More informationInformation to Make your Visit at the Clinic Smoother
Being ALIVE! Newsletter Winter 2012 Letter from Lisa McCall, Director The ALIVE Study has reached its 25th year! In the world of research, that s a very long time. And it s also a long time for participants
More informationParticipant Information Leaflet
Participant Information Leaflet Research: Hand to nose transmission of Streptococcus pneumoniae in healthy participants: randomised control trial assessing the effect of hand Would you like to take part
More informationTerry Talks Nutrition: Heart Disease
Terry Talks Nutrition: Heart Disease America s #1 Killer Did you know that heart disease (high blood pressure, heart failure and stroke) is the leading cause of death for Americans? Heart disease kills
More information14-2: Blood and Lymph. 7 th Grade Life Science
7 th Grade Life Science Blood Blood has four components: 1. Plasma 2. Red blood cells 3. White blood cells 4. Platelets Plasma Plasma is the liquid part of blood 90% of which is water. The other 10% is
More informationHeart Failure. Team. Project Details Color(s): CMYK File Name: CST3844_NM13_TCO_Heart_Failure_Broch.indd. Round 3
Taking Charge of Heart Failure CST844_NM1_TCO_Heart_Failure_Broch.indd 1 Job: CST844 NM1 TCO CST844_NM1_TCO_Heart_Failure_Broch.indd You can take charge of heart failure. Heart failure means that your
More information2018 in Review: Research Progress
2018 in Review: Research Progress Discoveries are crystallizing at a rapid pace through the most robust Parkinson s disease (PD) drug development pipeline in the history of the disease. And, Parkinson
More informationNutrition 2000 for Successful Aging
Nutrition 2000 for Successful Aging Population Trends In 1960, 8.1 percent (244 million people) of the world s population was 60 years of age and over. If current growth rates continue, by 2020, 12.8 percent
More informationHealthy Mouth, Healthy You. The connection between oral and overall health
Healthy Mouth, Healthy You The connection between oral and overall health Your dental health is part of a bigger picture: whole-body wellness. Learn more about the relationship between your teeth, gums
More informationThe Parkinson Progression Marker Initiative (PPMI) WW-ADNI July
The Parkinson Progression Marker Initiative (PPMI) WW-ADNI July 15 2011 Rationale for PPMI: Challenges of disease-modifying trials Disease modifying PD therapeutics remain a major unmet need A major obstacle
More informationSmoking & heart disease. Where there s smoke
Smoking & heart disease Where there s smoke The truth about smoking It s a common belief that smoking is a habit or lifestyle choice. But the truth is that it s a chemical addiction. What if I need help?
More informationMannitol - A natural food supplement shown to arrest Parkinson's progression and reverse symptoms
Mannitol - A natural food supplement shown to arrest Parkinson's progression and reverse symptoms A www.fight-parkinsons.org report This could be a game-changer for many people You just never know what
More informationPreventive Care: A National Profile on Use, Disparities, and Health Benefits
Eduardo Sanchez, MD, MPH Director, Institute for Health Policy University of Texas School of Public Health Chair, National Commission on Prevention Priorities Preventive Care: A National Profile on Use,
More informationRecent Advances in the cause and treatment of Parkinson disease. Anthony Schapira Head of Dept. Clinical Neurosciences UCL Institute of Neurology UCL
Recent Advances in the cause and treatment of Parkinson disease Anthony Schapira Head of Dept. Clinical Neurosciences UCL Institute of Neurology UCL SOME BACKGROUND incidence rate (per 100.000 person years)
More informationModule 30. Learning by Observation
Module 30 Learning by Observation 1 Module 30 Describe the process of observational learning, and explain how some scientists believe it is enabled by mirror neurons. Discuss the impact of prosocial modeling
More informationA Simulation of DNA Mutations and Cancer
Lab 13 A Simulation of DNA Mutations and Cancer PROBLEM How can the changes in DNA that lead to cancer be modeled? BACKGROUND Cancer is the uncontrolled growth of cells that produces tumors. Cancer is
More informationCANCER 1.7 M 609,000 26% 15.5 M 73% JUST THE FACTS. More Than 1,100 Cancer Treatments in Clinical Testing Offer Hope to Patients
CANCER MEDICINES IN DEVELOPMENT 2018 REPORT JUST THE FACTS MORE THAN 1.7 M ESTIMATED NEW CASES OF CANCER IN 2018 IN THE UNITED STATES MORE THAN 609,000 U.S. CANCER DEATHS ARE EXPECTED IN 2018 SINCE PEAKING
More informationImmunotherapy Narrative Script:
Immunotherapy Narrative Script: In order to understand immunotherapy, there are a few things we need to get straight in our heads first. The first thing we need to get a general understanding of is what
More informationPresented by Meagan Koepnick, Josh McDonald, Abby Narayan, Jared Szabo Mentored by Dr. Doorn
Presented by Meagan Koepnick, Josh McDonald, Abby Narayan, Jared Szabo Mentored by Dr. Doorn Objectives What agents do we currently have available and what do we ideally need? What biomarkers exist for
More informationA Case Review: Treatment-Naïve Patient with Head and Neck Cancer
Transcript Details This is a transcript of a continuing medical education (CME) activity accessible on the ReachMD network. Additional media formats for the activity and full activity details (including
More informationSAFETY E-CIGS: CLINICAL STUDIES
SAFETY E-CIGS: CLINICAL STUDIES SAFETY ECIGS: clinical studies Source: Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: A systematic review. Ther Adv Drug
More informationBiology Core B1. Drugs revision 09/06/ minutes. 43 marks. Page 1 of 17
Biology Core B Drugs revision 09/06/4 43 minutes 43 marks Page of 7 Q. Cannabis is an illegal drug. (a) What type of illness might be caused by smoking cannabis regularly? () (b) The graph shows the use
More information